Rasmus Bo Hasselbalch

Rasmus Bo Hasselbalch is a Postdoc researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, specifically within the Department of Clinical Medicine. He works in the Rasmussen Group and is based at Blegdamsvej 3B, Mærsk Tårnet, 7. sal, 2200 København N.

His research focuses on cardiology, clinical trials, biomarkers, metabolomics, and epidemiology, with particular emphasis on myocardial infarction, heart failure, and cardiac biomarkers. Dr. Hasselbalch has published extensively in high-impact journals including The Lancet Regional Health - Europe, Circulation, and Journal of the American Heart Association.

His recent work demonstrates expertise in cardiac biomarker kinetics, metabolomics of myocardial ischemia, clinical trial design, and cardiovascular pharmacology. He has contributed to important studies on troponin clearance, β3-adrenoceptor agonist treatments for heart failure, and the DANSPOT trial for reclassification of acute myocardial infarction.

Dr. Hasselbalch collaborates extensively with leading researchers including Bundgaard, H., Iversen, K.K., and other prominent figures in cardiovascular medicine. His work has been cited in multiple publications and has attracted attention from news outlets and social media platforms.